{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:03:34Z","timestamp":1784077414445,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200222"],"award-info":[{"award-number":["82200222"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10201-3","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:54:11Z","timestamp":1778201651000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Upregulation of TCF1 and BCL11B in CD8+ effector T cells predicts favorable response to ibrutinib in patients with chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"9","author":[{"given":"Ge","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taotao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songke","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Luv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"10201_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.6004\/jnccn.2024.0018","volume":"22","author":"WG Wierda","year":"2024","unstructured":"Wierda, W. G. et al. Chronic lymphocytic leukemia\/small lymphocytic lymphoma, version 2.2024, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Cancer Netw. 22, 175\u2013204 (2024).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10201_CR2","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41375-019-0602-x","volume":"34","author":"JA Burger","year":"2020","unstructured":"Burger, J. A. et al. Long-term efficacy and safety of first-line ibrutinib treatment for patients with CLL\/SLL: 5 years of follow-up from the phase 3 RESONATE-2 study. Leukemia 34, 787\u2013798 (2020).","journal-title":"Leukemia"},{"key":"10201_CR3","doi-asserted-by":"publisher","first-page":"962552","DOI":"10.3389\/fimmu.2022.962552","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu, Y. et al.Effects of ibrutinib on T-cell immunity in patients with chronic lymphocytic leukemia. Front. Immunol. 13, 962552 (2022).","journal-title":"Front. Immunol."},{"key":"10201_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1201415","volume":"14","author":"L Li","year":"2023","unstructured":"Li, L. et al. Ibrutinib directly reduces CD8+T cell exhaustion independent of BTK. Front. Immunol. 14, 1201415 (2023).","journal-title":"Front. Immunol."},{"key":"10201_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54654-8","volume":"16","author":"IR Leo","year":"2025","unstructured":"Leo, I. R. et al. Functional proteoform group deconvolution reveals a broader spectrum of ibrutinib off-targets. Nat. Commun. 16, 1948 (2025).","journal-title":"Nat. Commun."},{"key":"10201_CR6","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.4049\/jimmunol.1601190","volume":"198","author":"QS Yin","year":"2017","unstructured":"Yin, Q. S. et al. Ibrutinib therapy increases T cell repertoire diversity in patients with chronic lymphocytic leukemia. J. Immunol. 198, 1740\u20131747 (2017).","journal-title":"J. Immunol."},{"key":"10201_CR7","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1172\/JCI89756","volume":"127","author":"M Long","year":"2017","unstructured":"Long, M. et al. Ibrutinib treatment improves T cell number and function in CLL patients. J. Clin. Investig. 127, 3052\u20133064 (2017).","journal-title":"J. Clin. Investig."},{"key":"10201_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1182\/blood.2023020554","volume":"143","author":"D Papazoglou","year":"2024","unstructured":"Papazoglou, D. et al. Ibrutinib-based therapy reinvigorates CD8+ T cells compared to chemoimmunotherapy: immune monitoring from the E1912 trial. Blood 143, 57\u201363 (2024).","journal-title":"Blood"},{"key":"10201_CR9","doi-asserted-by":"publisher","first-page":"217771","DOI":"10.1016\/j.canlet.2025.217771","volume":"626","author":"YT Bao","year":"2025","unstructured":"Bao, Y. T. et al. The mechanisms and countermeasures for CAR-T cell expansion and persistence deficiency. Cancer Lett. 626, 217771 (2025).","journal-title":"Cancer Lett."},{"key":"10201_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-024-01193-6","volume":"14","author":"Z Tao","year":"2024","unstructured":"Tao, Z. et al. Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies. Blood Cancer J. 14, 213 (2024).","journal-title":"Blood Cancer J."},{"key":"10201_CR11","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood.2023021306","volume":"143","author":"A Minson","year":"2024","unstructured":"Minson, A. et al. CAR T cells and time-limited ibrutinib as treatment for relapsed\/refractory mantle cell lymphoma: the phase 2 TARMAC study. Blood 143, 673\u2013684 (2024).","journal-title":"Blood"},{"key":"10201_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1620","volume":"14","author":"L Huang","year":"2024","unstructured":"Huang, L. et al. Unlocking the potential of T-cell metabolism reprogramming: advancing single-cell approaches for precision immunotherapy in tumour immunity. Clin. Transl. Med. 14, e1620 (2024).","journal-title":"Clin. Transl. Med."},{"key":"10201_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","volume":"42","author":"A Baessler","year":"2024","unstructured":"Baessler, A. & Vignali, D. A. A. T cell exhaustion. Annu. Rev. Immunol. 42, 179\u2013206 (2024).","journal-title":"Annu. Rev. Immunol."},{"key":"10201_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.tmrv.2019.01.005","volume":"33","author":"EJM Grigor","year":"2019","unstructured":"Grigor, E. J. M. et al. Risks and benefits of chimeric antigen receptor T-Cell (CAR-T) therapy in cancer: a systematic review and meta-analysis. Transfus. Med. Rev. 33, 98\u2013110 (2019).","journal-title":"Transfus. Med. Rev."},{"key":"10201_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.immuni.2023.12.006","volume":"57","author":"K Abadie","year":"2024","unstructured":"Abadie, K. et al. Reversible, tunable epigenetic silencing of TCF1 generates flexibility in the T cell memory decision. Immunity 57, 271\u2013286.e13 (2024).","journal-title":"Immunity"},{"key":"10201_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41577-021-00563-6","volume":"22","author":"X Zhao","year":"2022","unstructured":"Zhao, X. et al. TCF1 in T cell immunity: a broadened frontier. Nat. Rev. Immunol. 22, 147\u2013157 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"10201_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16219-3","volume":"11","author":"SPM Welten","year":"2020","unstructured":"Welten, S. P. M. et al. Tcf1+ cells are required to maintain the inflationary T cell pool upon MCMV infection. Nat. Commun. 11, 2295 (2020).","journal-title":"Nat. Commun."},{"key":"10201_CR18","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-019-1836-5","volume":"576","author":"CS Jansen","year":"2019","unstructured":"Jansen, C. S. et al. An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature 576, 465\u2013470 (2019).","journal-title":"Nature"},{"key":"10201_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2020.11.035","volume":"499","author":"HS Han","year":"2021","unstructured":"Han, H. S. et al. TOX-expressing terminally exhausted tumor-infiltrating CD8+ T cells are reinvigorated by co-blockade of PD-1 and TIGIT in bladder cancer. Cancer Lett. 499, 137\u2013147 (2021).","journal-title":"Cancer Lett."},{"key":"10201_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58510-1","volume":"16","author":"SL Zhang","year":"2025","unstructured":"Zhang, S. L. et al. Combination radiation and \u03b1PD-L1 enhance tumor control by stimulating CD8+\u2009PD-1+\u2009TCF-1+\u2009T cells in the tumor-draining lymph node. Nat. Commun. 16, 3522 (2025).","journal-title":"Nat. Commun."},{"key":"10201_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1182\/blood.2021011597","volume":"139","author":"CR Funk","year":"2022","unstructured":"Funk, C. R. et al. PI3K\u03b4\/\u03b3 inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity. Blood 139, 523\u2013537 (2022).","journal-title":"Blood"},{"key":"10201_CR22","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1182\/blood.2019001795","volume":"134","author":"K Patel","year":"2019","unstructured":"Patel, K. et al. Duvelisib for CLL\/SLL and follicular non-Hodgkin lymphoma. Blood 134, 1573\u20131577 (2019).","journal-title":"Blood"},{"key":"10201_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.immuni.2018.01.012","volume":"48","author":"JL Johnson","year":"2018","unstructured":"Johnson, J. L. et al. Lineage-determining transcription factor TCF-1 initiates the epigenetic identity of T cells. Immunity 48, 243\u2013257.e10 (2018).","journal-title":"Immunity"},{"key":"10201_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3389\/fimmu.2016.00425","volume":"7","author":"G Abboud","year":"2016","unstructured":"Abboud, G. et al. Transcription factor Bcl11b controls effector and memory CD8 T cell fate decision and function during poxvirus infection. Front. Immunol. 7, 425 (2016).","journal-title":"Front. Immunol."},{"key":"10201_CR25","doi-asserted-by":"publisher","first-page":"985280","DOI":"10.3389\/fimmu.2022.985280","volume":"13","author":"T Liang","year":"2022","unstructured":"Liang, T. et al. Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemia. Front. Immunol. 13, 985280 (2022).","journal-title":"Front. Immunol."},{"key":"10201_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101447","volume":"8","author":"X Wang","year":"2021","unstructured":"Wang, X. et al. Single-cell RNA-Seq of T cells in B-ALL patients reveals an exhausted subset with remarkable heterogeneity. Adv. Sci. 8, e2101447 (2021).","journal-title":"Adv. Sci."},{"key":"10201_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012526","volume":"20","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyond. PLoS Pathog. 20, e1012526 (2024).","journal-title":"PLoS Pathog."},{"key":"10201_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-020-00253-w","volume":"8","author":"S Cadot","year":"2020","unstructured":"Cadot, S. et al. Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse. Biomark. Res. 8, 72 (2020).","journal-title":"Biomark. Res."},{"key":"10201_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1817","volume":"14","author":"L Ni","year":"2024","unstructured":"Ni, L. Potential mechanisms of cancer stem-like progenitor T-cell bio-behaviours. Clin. Transl. Med. 14, e1817 (2024).","journal-title":"Clin. Transl. Med."},{"key":"10201_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41435-024-00263-w","volume":"25","author":"JM Garc\u00eda-Aznar","year":"2024","unstructured":"Garc\u00eda-Aznar, J. M. et al. Pivotal role of BCL11B in the immune, hematopoietic and nervous systems: a review of the BCL11B-associated phenotypes from the genetic perspective. Genes. Immun. 25, 232\u2013241 (2024).","journal-title":"Genes. Immun."},{"key":"10201_CR31","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.immuni.2020.09.005","volume":"53","author":"D Pais Ferreira","year":"2020","unstructured":"Pais Ferreira, D. et al. Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation. Immunity 53, 985\u20131000.e11 (2020).","journal-title":"Immunity"},{"key":"10201_CR32","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41590-024-01864-3","volume":"25","author":"N Gamble","year":"2024","unstructured":"Gamble, N. et al. PU.1 and BCL11B sequentially cooperate with RUNX1 to anchor mSWI\/SNF to poise the T cell effector landscape. Nat. Immunol. 25, 1123 (2024).","journal-title":"Nat. Immunol."},{"key":"10201_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41590-023-01685-w","volume":"25","author":"Z Zhu","year":"2024","unstructured":"Zhu, Z. et al. FOXP1 and KLF2 reciprocally regulate checkpoints of stem-like to effector transition in CAR T cells. Nat. Immunol. 25, 117\u2013128 (2024).","journal-title":"Nat. Immunol."},{"key":"10201_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/978-1-4939-3578-9_5","volume":"1418","author":"E Clough","year":"2016","unstructured":"Clough, E. & Barrett, T. The gene expression omnibus database. Methods Mol. Biol. 1418, 93\u2013110 (2016).","journal-title":"Methods Mol. Biol."},{"key":"10201_CR35","doi-asserted-by":"publisher","first-page":"W216","DOI":"10.1093\/nar\/gkac194","volume":"50","author":"BT Sherman","year":"2022","unstructured":"Sherman, B. T. et al. DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 50, W216\u2013W221 (2022).","journal-title":"Nucleic Acids Res."},{"key":"10201_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang, D. W. et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"10201_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14081-6","volume":"11","author":"AF Rendeiro","year":"2020","unstructured":"Rendeiro, A. F. et al. Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL. Nat. Commun. 11, 577 (2020).","journal-title":"Nat. Commun."},{"key":"10201_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-3-21","volume":"3","author":"A Gribov","year":"2010","unstructured":"Gribov, A. et al. SEURAT: visual analytics for the integrated analysis of microarray data. Bmc. Med. Genom. 3, 21 (2010).","journal-title":"Bmc. Med. Genom."},{"key":"10201_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"10201_CR40","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G. et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284\u2013287 (2012).","journal-title":"OMICS"},{"key":"10201_CR41","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41590-025-02192-w","volume":"26","author":"Y Hu","year":"2025","unstructured":"Hu, Y. et al. CARD11 signaling regulates CD8+ T cell tumoricidal function. Nat. Immunol. 26, 1113\u20131126 (2025).","journal-title":"Nat. Immunol."},{"key":"10201_CR42","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.it.2023.02.006","volume":"44","author":"R Zander","year":"2023","unstructured":"Zander, R. & Cui, W. Exhausted CD8+ T cells face a developmental fork in the road. Trends Immunol. 44, 276\u2013286 (2023).","journal-title":"Trends Immunol."},{"key":"10201_CR43","unstructured":"R. Core Team. _R: A language and environment for statistical computing_. R foundation for statistical computing, Vienna, Austria (2024)."},{"key":"10201_CR44","doi-asserted-by":"publisher","unstructured":"Liu, G. Code for analysis of TCF1 and BCL11B expression in ibrutinib-treated CLL. (V1.0.0). [Computer software]. Zenodo. https:\/\/doi.org\/10.5281\/zenodo.19597053 (2026).","DOI":"10.5281\/zenodo.19597053"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10201-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10201-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:03:25Z","timestamp":1784073805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10201-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10201"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10201-3","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"957"}}